Chargement en cours...
Targeting mTOR in Acute Lymphoblastic Leukemia
Acute Lymphoblastic Leukemia (ALL) is an aggressive hematologic disorder and constitutes approximately 25% of cancer diagnoses among children and teenagers. Pediatric patients have a favourable prognosis, with 5-years overall survival rates near 90%, while adult ALL still correlates with poorer surv...
Enregistré dans:
| Publié dans: | Cells |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6406494/ https://ncbi.nlm.nih.gov/pubmed/30795552 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells8020190 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|